Finance

Lists
DAP:ETR
Danaher Corp
208,90 €
-1,46%
(-3,10) 1D
13 նոյ, 17:35:43 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DAP...
Open
210,30 €
High
211,00 €
Low
208,70 €
Mkt. cap
163,94 մլրդ
Avg. vol.
549,00
Volume
426,00
52-wk high
214,50 €
52-wk low
138,20 €
No. of employees
59 հզր
Open
210,30 €
High
211,00 €
Low
208,70 €
Mkt. cap
163,94 մլրդ
Avg. vol.
549,00
Volume
426,00
52-wk high
214,50 €
52-wk low
138,20 €
No. of employees
59 հզր
News stories
From web sources and news partners
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees59 հզր
Founded1969
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
17,51%
17,29%
13,89%
18,84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps